Listen in!
The standard of care for diagnosing coronary artery disease (CAD) has changed. CCTA paired with AI-powered Plaque Analysis has emerged as a tool of choice to identify, risk stratify and stage CAD, and notably, manage and treat patients in a far more informed way. Join us to hear from three key opinion leaders as they present data and new case studies demonstrating how Plaque Analysis can help with diagnosis and management of patients with suspected CAD. One physician even shares how he has benefitted from CCTA + Plaque Analysis. It’s a great story.
Learn from our experts about:
- The benefits of using plaque analysis in the diagnosis and management of CAD patients
- What the DECIDE Registry staging framework is and how that can help inform treatment changes
- How optimizing treatment based on total plaque volume can improve patient outcomes (i.e. case studies with lowered Lp(a), LDL, etc)
- Why physicians need to shift their mindset from risk to disease much like oncologists and treat based on the understanding of the specific disease, its presence and severity or stage.
Who should watch:
- Cardiologists and Interventional Cardiologists
- Cardiovascular Imaging Specialists
- Radiologists VPs, Directors and Managers, Cardiovascular Service Line
- VPs, Directors and Managers, Radiology and Imaging
- Cath Lab Directors
- CV Nurses, NPs, PAs
- 3D Lab Directors and Managers
- CT Technologists
 Allen Taylor, MD, FACC, FAHA |  Anandita Kulkarni, MD, FACC |  Sujith Kalathiveetil, MD, FACC |